查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1652018

CRISPR·Cas遗传基因的全球市场:市场规模·占有率·趋势，产业分析 (各类型·各用途·各终端用户·各地区)，未来预测 (2025年～2034年)

CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type, Application, End User, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球 CRISPR/Cas 基因市场预计到 2034 年将达到 228.2 亿美元。该报告提供了有关当前市场动态的详细见解，并对未来市场的成长进行了分析。

CRISPR 和 Cas 基因市场包括将 CRISPR 和 Cas 技术用于医学、农业和生物技术领域的基因编辑应用。该技术可以精确修改 DNA，从而推动基因研究、疾病治疗和作物改良的进步。由于其具有彻底改变个人化医疗、基因治疗和农业实践的潜力，该市场正在快速成长。关键推动因素包括对基因研究的投资增加、对基因治疗的需求不断增长以及对更永续的农业解决方案的需求。然而，道德问题和监管障碍可能会阻碍市场扩张。

基因编辑技术的进步、基因研究投入的增加以及医疗保健、农业和生物技术领域的应用不断扩大，推动了 CRISPR 和 Cas 基因市场的需求不断增长。关键推动因素包括基于 CRISPR 的疗法治疗遗传疾病的潜力、对具有改良性状的转基因作物日益增长的需求、以及对高效药物发现工具日益增长的需求。 CRISPR-Cas基因的市场机会在于个人化医疗的开发、罕见疾病的基因治疗以及将CRISPR融入农业生物技术以实现永续粮食生产。主要趋势包括向下一代 CRISPR 技术的转变、基因治疗临床试验的增加以及生物技术公司和学术机构之间更强的研究合作。

CRISPR/Cas 基因市场：概论

该产品领域占据了最大的市场占有率，这得益于对基因编辑研究和应用的 CRISPR 工具、试剂和试剂盒的高需求。由于将 CRISPR 相关研究和开发外包给合约研究组织 (CRO)，服务领域正在经历最高的成长。

由于 CRISPR 在针对遗传疾病、癌症和个人化医疗的基因治疗中的应用越来越多，生物医学领域在市场中占据主导地位。农业领域是成长最快的领域，因为 CRISPR 技术被用于改良作物特性和提高粮食安全。

生物技术和製药公司占最大占有率，对基于 CRISPR 的遗传疾病治疗方法和药物研发进行了大量投资。 CRO 和 CDMO 领域成长最快，因为这些组织在为生技公司提供临床试验和基因编辑服务方面发挥关键作用。

北美凭藉强大的生物技术产业、大量研发投入以及对基因编辑技术的监管支持占据市场主导地位。亚太地区是成长最快的地区，中国和印度等国家正迅速采用 CRISPR 技术。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 CRISPR·Cas遗传基因市场洞察

  • 市场概述
  • CRISPR·Cas遗传基因的市场动态
    • 促进因素和机会
      • 基于 CRISPR 的治疗最终使用者的进步 CRISPR 在农业生物应用的应用日益广泛
    • 阻碍因素和课题
      • 分销课题
  • 大环境分析
  • CRISPR·Cas遗传基因市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球CRISPR·Cas遗传基因市场:各类型

  • 主要的分析结果
  • 简介
  • 产品
  • 服务

第6章 全球CRISPR·Cas遗传基因市场:各用途

  • 主要的分析结果
  • 简介
  • 生物医学
  • 农业

第7章 全球CRISPR·Cas遗传基因市场:各终端用户

  • 主要的分析结果
  • 简介
  • 生物科技·製药企业
  • 学术机构·政府调查机关
  • CRO·CDMO

第8章 全球CRISPR·Cas遗传基因市场:各地区

  • 主要的分析结果
  • 简介
    • CRISPR·Cas遗传基因市场评估:各地区 (2020～2034年)
  • 北美
    • 北美:各类型 (2020～2034年)
    • 北美:各用途 (2020～2034年)
    • 北美:各终端用户 (2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型 (2020～2034年)
    • 欧洲:各用途 (2020～2034年)
    • 欧洲:各终端用户 (2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型 (2020～2034年)
    • 亚太地区:各用途 (2020～2034年)
    • 亚太地区:各终端用户 (2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型 (2020～2034年)
    • 中东·非洲:各用途 (2020～2034年)
    • 中东·非洲:各终端用户 (2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各类型 (2020～2034年)
    • 南美:各用途 (2020～2034年)
    • 南美:各终端用户 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Caribou Biosciences
  • Sangamo Therapeutics
  • Agilent Technologies
  • Addgene
  • Thermo Fisher Scientific
  • Illumina
  • Life Technologies
  • Precision Biosciences
  • Beam Therapeutics
  • Cellectis
  • Gene Editing Technologies
  • Horizon Discovery
Product Code: PM1738

The global CRISPR & Cas genes market size is expected to reach USD 22.82 billion by 2034, according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type (Products and Services), Application (Biomedical and Agricultural), End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The CRISPR & Cas genes market involves the use of CRISPR-Cas technology for gene editing applications in medicine, agriculture, and biotechnology. This technology allows precise modifications to DNA, enabling advancements in genetic research, disease treatment, and crop improvement. The market is experiencing rapid growth due to its potential to revolutionize personalized medicine, gene therapies, and agricultural practices. Key drivers include increasing investment in genetic research, rising demand for gene therapies, and the need for more sustainable agricultural solutions. However, ethical concerns and regulatory hurdles may affect market expansion.

The rising CRISPR & Cas genes market demand is attributed to advancements in gene-editing technologies, increased investments in genetic research, and expanding applications in healthcare, agriculture, and biotechnology. Key drivers include the potential for CRISPR-based therapies to treat genetic disorders, the growing demand for genetically modified crops with enhanced traits, and the rising need for efficient drug discovery tools. CRISPR & Cas genes market opportunities lie in the development of personalized medicine, gene therapies for rare diseases, and CRISPR's integration into agricultural biotechnology for sustainable food production. Major trends include the shift toward next-generation CRISPR technologies, an increase in clinical trials for gene therapies, and expanding research collaborations between biotech firms and academic institutions.

CRISPR & Cas Genes Market Report Highlights

The products segment holds the largest market share, driven by high demand for CRISPR tools, reagents, and kits for gene-editing research and applications. The services segment is experiencing the highest growth, fueled by increasing outsourcing of CRISPR-related research and development to contract research organizations (CROs).

The biomedical segment dominates the market, driven by the increasing use of CRISPR for gene therapies targeting genetic disorders, cancer, and personalized medicine. The agricultural segment is the fastest-growing, as CRISPR technologies are being leveraged to enhance crop traits and improve food security.

Biotechnology & pharmaceutical companies hold the largest share, investing heavily in CRISPR-based therapies for genetic diseases and drug discovery. The CRO and CDMO segment is growing the fastest, as these organizations play a critical role in advancing clinical trials and gene-editing services for biotech firms.

North America dominates the market, driven by a strong biotechnology sector, significant R&D investments, and regulatory support for gene-editing technologies. Asia-Pacific is the highest-growing region, with rapid adoption of CRISPR technologies in countries like China and India, focusing on both healthcare and agricultural applications.

Polaris Market Research has segmented the CRISPR & Cas Genes market report on the basis of type, application, end user, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • Products
  • Services

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Biomedical
  • Agricultural

By End User Outlook (Revenue - USD Billion, 2020-2034)

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CRO) & CDMOs

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global CRISPR & Cas Genes Market Insights

  • 4.1. CRISPR & Cas Genes Market - Market Snapshot
  • 4.2. CRISPR & Cas Genes Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in CRISPR-Based Therapeutic End Users
      • 4.2.1.2. Increasing Use of CRISPR in Agricultural BioApplication
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Delivery challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. CRISPR & Cas Genes Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global CRISPR & Cas Genes Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Product
    • 5.3.1. Global CRISPR & Cas Genes Market, by Product, by Region, 2020-2034 (USD Billion)
  • 5.4. Services
    • 5.4.1. Global CRISPR & Cas Genes Market, by Services, by Region, 2020-2034 (USD Billion)

6. Global CRISPR & Cas Genes Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Biomedical
    • 6.3.1. Global CRISPR & Cas Genes Market, by Biomedical, by Region, 2020-2034 (USD Billion)
  • 6.4. Agricultural
    • 6.4.1. Global CRISPR & Cas Genes Market, by Agricultural, by Region, 2020-2034 (USD Billion)

7. Global CRISPR & Cas Genes Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Biotechnology & Pharmaceutical Companies
    • 7.3.1. Global CRISPR & Cas Genes Market, by Biotechnology & Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.4. Academics & Government Research Institutes
    • 7.4.1. Global CRISPR & Cas Genes Market, by Academics & Government Research Institutes, by Region, 2020-2034 (USD Billion)
  • 7.5. Contract Research Organizations (CRO) & CDMOs
    • 7.5.1. Global CRISPR & Cas Genes Market, by Contract Research Organizations (CRO) & CDMOs, by Region, 2020-2034 (USD Billion)

8. Global CRISPR & Cas Genes Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. CRISPR & Cas Genes Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. CRISPR & Cas Genes Market - North America
    • 8.3.1. North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. CRISPR & Cas Genes Market - U.S.
      • 8.3.4.1. U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. CRISPR & Cas Genes Market - Canada
      • 8.3.5.1. Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.4. CRISPR & Cas Genes Market - Europe
    • 8.4.1. Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. CRISPR & Cas Genes Market - UK
      • 8.4.4.1. UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. CRISPR & Cas Genes Market - France
      • 8.4.5.1. France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. CRISPR & Cas Genes Market - Germany
      • 8.4.6.1. Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. CRISPR & Cas Genes Market - Italy
      • 8.4.7.1. Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. CRISPR & Cas Genes Market - Spain
      • 8.4.8.1. Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. CRISPR & Cas Genes Market - Netherlands
      • 8.4.9.1. Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. CRISPR & Cas Genes Market - Russia
      • 8.4.10.1. Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. CRISPR & Cas Genes Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.5. CRISPR & Cas Genes Market - Asia Pacific
    • 8.5.1. Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. CRISPR & Cas Genes Market - China
      • 8.5.4.1. China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. CRISPR & Cas Genes Market - India
      • 8.5.5.1. India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. CRISPR & Cas Genes Market - Malaysia
      • 8.5.6.1. Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. CRISPR & Cas Genes Market - Japan
      • 8.5.7.1. Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. CRISPR & Cas Genes Market - Indonesia
      • 8.5.8.1. Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. CRISPR & Cas Genes Market - South Korea
      • 8.5.9.1. South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. CRISPR & Cas Genes Market - Australia
      • 8.5.10.1. Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. CRISPR & Cas Genes Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.6. CRISPR & Cas Genes Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. CRISPR & Cas Genes Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. CRISPR & Cas Genes Market - UAE
      • 8.6.5.1. UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. CRISPR & Cas Genes Market - Israel
      • 8.6.6.1. Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. CRISPR & Cas Genes Market - South Africa
      • 8.6.7.1. South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. CRISPR & Cas Genes Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • 8.7. CRISPR & Cas Genes Market - Latin America
    • 8.7.1. Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. CRISPR & Cas Genes Market - Mexico
      • 8.7.4.1. Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. CRISPR & Cas Genes Market - Brazil
      • 8.7.5.1. Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. CRISPR & Cas Genes Market - Argentina
      • 8.7.6.1. Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. CRISPR & Cas Genes Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. CRISPR Therapeutics
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Editas Medicine
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Intellia Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Caribou Biosciences
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Sangamo Therapeutics
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Agilent Technologies
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Addgene
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Thermo Fisher Scientific
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Illumina
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Life Technologies
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Precision Biosciences
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Beam Therapeutics
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Cellectis
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Gene Editing Technologies
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Horizon Discovery
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables:

  • Table 1 Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global CRISPR & Cas Genes Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global CRISPR & Cas Genes Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global CRISPR & Cas Genes Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global CRISPR & Cas Genes Market, by End User, 2024 & 2034 (USD Billion)